Aura Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,238 | $0 |
Gross Profit | -300 | -291 | 619 | -313 |
EBITDA | -26,671 | -27,174 | -27,516 | -22,919 |
EBIT | -26,971 | -27,465 | -27,807 | -23,232 |
Net Income | -27,019 | -27,483 | -25,834 | -21,042 |
Net Change In Cash | 0 | 0 | 1,238 | 0 |
Free Cash Flow | -20,813 | -23,542 | -24,251 | -15,614 |
Cash | 107,367 | 38,226 | 31,693 | 25,407 |
Basic Shares | 58,015 | 50,126 | 49,650 | 49,663 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,223 | -1,295 | -1,177 | -835 |
EBITDA | -85,584 | -83,696 | -59,118 | -34,416 |
EBIT | -86,807 | -84,991 | -60,295 | -35,251 |
Net Income | -86,919 | -76,408 | -58,763 | -35,251 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -26,841 | 131,724 | ||
Free Cash Flow | -81,058 | -64,556 | -55,695 | -34,535 |
Cash | 31,693 | 41,063 | 121,582 | 149,063 |
Basic Shares | 49,650 | 39,620 | 29,937 | 29,211 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.47 |
2025-03-31 | -$0.55 |
2024-12-31 | -$0.52 |
